Kaleido Biosciences Earning Date (KLDO)

USA |NASDAQ |USD

KLDO Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Mar 1, 2022 Dec 2021 $-0.59 $-0.54 $-0.56
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Mar 1, 2022 Dec 2021 $1.12M $104.00K $243.00K

Kaleido Biosciences's next earnings date is Tuesday, Mar 1, 2022 for the fiscal quarter ending Dec 2021.

KLDO Earnings Date & History Chart

KLDO Earnings & Revenue Forecast

KLDO Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 6 $-0.59 $-0.84 $-0.41
Mar 2022 3 $-0.46 $-0.58 $-0.39
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 6 $-2.27 $-2.53 $-2.08
Dec 2022 6 $-2.18 $-2.66 $-1.61

KLDO Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 3 / 1 $-0.57 $-0.57 $-0.51
Mar 2022 3 / 0 $-0.51 $-0.51 $-0.50
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 4 / 0 $-2.25 $-2.25 $-2.29
Dec 2022 5 / 0 $-2.40 $-2.40 $-2.34

KLDO Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 5 $1.12M $0.00 $5.20M
Mar 2022 2 $120.00K $0.00 $250.00K
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 5 $840.00K $610.00K $1.00M
Dec 2022 6 $530.00K $0.00 $1.20M

KLDO Earnings Date & Revenue History

KLDO Earnings History

|
Show More
Show More

KLDO Revenue History

|
Show More
Show More

Kaleido Biosciences Next Earnings Date & Report

KLDO Next Earnings Date & Report Preview: Dec 2021 (FQ)

KLDO's next earnings date is Tuesday, Mar 1, 2022 for the fiscal quarter ending Dec 31, 2021.

According to 6 analysts, the average EPS estimation for Kaleido Biosciences's next quarterly earnings is $-0.59, with a low EPS estimation of $-0.84, and a high estimation of $-0.41.

Over the last 1 month, EPS estimates have seen 3 upward revisions and 1 downward. The EPS 1 month trend is $-0.57, the last 2 month trend is $-0.57, and the 3 month trend is $-0.51.

Based on 5 analysts, the average revenue estimation is $1.12M, with a low revenue estimation of $0.00, and a high estimation of $5.20M.

Kaleido Biosciences Previous Earnings Dates & Reports

KLDO Previous Earnings Date & Report Recap: Sep 2021 (FQ)

Kaleido Biosciences's previous earnings date was Nov 1, 2021 for its fiscal quarter ended Sep 30, 2021.

KLDO's earnings per share (EPS) was $-0.54, missing the consensus analysts forecast of $-0.54 by -0.80%.

The EPS was higher than the previous fiscal quarter (Jun 2021) by -3.57%, and higher than the same period a year before (Sep 2020) by -16.92%.

Revenues were $104.00K, worse than the forecast of $170.00K by -38.82%, down by -50.71% from the previous quarter , and down by -78.42% from the same period last year.

The company reported a net income of $-23.09M.

Free cash flow for the quarter was $-16.31M , compared to $-20.32M last quarter and $-17.93M a year before.

KLDO ended the quarter with $21.52M in total debt, an increase of 0.81% compared to the previous quarter, and an increase of 3.30% compared to the same quarter a year before.

KLDO Previous Earnings Date & Report Recap: Dec 2020 (FY)

Kaleido Biosciences's previous annual earnings date was Mar 3, 2021 for its fiscal year ended Dec 31, 2020.

KLDO's earnings per share (EPS) was $-2.44, missing the consensus analysts forecast of $-2.36 by 3.39% , and higher than the previous year's EPS (Dec 2019) by -15.86%.

Revenues were $975.00K.

The company reported a net income of $-81.62M.

Kaleido Biosciences reported a free cash flow of $-65.54M for its fiscal year, compared to $-79.38M a year ago.

The company ended the fiscal year with $21.01M in total debt, an increase of 2.69% compared to the previous year.